Our sp where it is, i guess the fate of the sp is in managements hands. I still beleive we are severly undervalued, as do others. I think the main reason our sp is suffering while most of the other juniors are getting close to old highs or past is because of the long periods in between results. I understand that we use the same lab as Ven and this may be connected to the long waits for assays. I see that there are so many companies out there that are putting out frequent news, some every week, and it shows in their sp that interest is attracted to these plays, hence pushing their sp,s to levels that are satisfying their shareholders.

Dont get me wrong here, I am not bashing but merely pointing out what I think is causing part of the undervalued situation. This company has huge potential, but a lot of patience is required til we get the right news.

I will post my thoughts on our last nr in the following week.